Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Rapid Medical, a company focused on the development of next-generation neurovascular devices, has announced CE Mark approval for the expanded...
Rapid Medical, a company focused on the development of next generation neurovascular devices, has announced that it received CE Mark for TIGERTRIEVER ...
Rapid Medical, a company focused on the development of next generation neurovascular interventional devices, has announced that it has completed...
Rapid Medical, a company focused on the development of next generation neurovascular devices, today announced that its Comaneci device received FDA...
Rapid Medical, a company focused on the development of interventional neurovascular devices, announced today that it has completed an oversubscribed...
Rapid Medical, a company focused on the development of next generation neurovascular devices, has announced that it has received CE Mark approval for ...
Die Daten aus der Studie werden an die FDA übermittelt, um die Marktfreigabe von TIGERTRIEVER in den USA zu unterstützen. Rapid Medical, ein...
Rapid Medical, a company focused on the development of next generation neurovascular interventional devices, has announced that the first patients...
Les données de l'étude seront communiquées à la FDA pour appuyer l'autorisation de commercialisation du TIGERTRIEVER aux États-Unis. Rapid Medical,...
Today, Rapid Medical, a company focused on the development of neurovascular interventional devices, announced that the first patient was enrolled to...
- Dieses Post-Market-Register soll die Sicherheit und Leistung des TIGERTRIEVER-Revaskularisierungsgerät in der Praxis bewerten. Rapid Medical, ein...
- Le registre post-commercialisation évaluera l'innocuité et les performances dans la vie réelle du dispositif de revascularisation TIGERTRIEVER...
Rapid Medical, a company focused on the development of neurovascular interventional devices, announced today that it has completed a Series B...
Ce financement a été mené par BRM Group et Shanghai-Israel Investment Fund Rapid Medical, une entreprise axée sur le développement de dispositifs...
Die Finanzierung wurde angeführt von der BRM Group und vom Shanghai-Israel Investment Fund Rapid Medical, ein Unternehmen, das sich auf die...
Ein innovatives Medizinprodukt für den Schutz des Trägergefäßes, während der Behandlung eines intrakraniellen Aneurysmen beeinflusst das Leben von...
Un dispositif innovant de protection des vaisseaux parents lors du traitement d'un anévrisme intracrânien sauve des vies dans le monde entier Rapid...
Rapid Medical, a company focused on the development of neurovascular interventional devices, announced today that the Comaneci Adjustable Remodeling...
Rapid Medical, a company focused on the development of neurovascular interventional devices, announced today that the first patient has been treated...
- Der einstellbare, vollkommen sichtbare TIGERTRIEVER ist für die Behandlung von Patienten mit Ischämischem Schlaganfall entwickelt worden. Rapid...
- TIGERTRIEVER, un dispositif contrôlable et entièrement visible, est conçu pour traiter les patients victimes d'accident ischémique cérébral Rapid...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.